Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MTOR”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00378703
What this trial is testing

Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v7
National Cancer Institute (NCI) 361
Testing effectiveness (Phase 2)Study completedNCT01077986
What this trial is testing

Everolimus, Cetuximab and Capecitabine in Patients With Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 35
Not applicableApproved For MarketingNCT03817515
What this trial is testing

Expanded Access for ABI-009 in Patients With Advanced PEComa and Patients With a Malignancy With Relevant Genetic Mutations or mTOR Pathway Activation

Who this might be right for
PEComa, MalignantTSC1TSC2+1 more
Aadi Bioscience, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT01582009
What this trial is testing

Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage III Renal Cell Cancer+1 more
Roswell Park Cancer Institute 26
Not applicableStudy completedNCT01184898
What this trial is testing

Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML)

Who this might be right for
AML
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 36
Large-scale testing (Phase 3)Study completedNCT06341998
What this trial is testing

Clinical Study of Chemotherapy in the Treatment of Recurrent/Refractory Yolk Sac Tumor in Children

Who this might be right for
Germ Cell TumorYolk Sac Tumor
Shandong First Medical University 32
Large-scale testing (Phase 3)Study completedNCT00789828
What this trial is testing

Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)

Who this might be right for
Tuberous SclerosisSubependymal Giant Cell Astrocytoma
Novartis Pharmaceuticals 117
Large-scale testing (Phase 3)Study completedNCT00876395
What this trial is testing

Everolimus in Combination With Trastuzumab and Paclitaxel in the Treatment of HER2 Positive Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 719
Early research (Phase 1)Study completedNCT01152801
What this trial is testing

Safety of RAD001 in Chinese Patients With Metastatic Renal Cell Cancer

Who this might be right for
Metastatic Renal Cell Carcinoma
Novartis Pharmaceuticals 64
Testing effectiveness (Phase 2)Study completedNCT00632268
What this trial is testing

Low-dose RAD001(Everolimus) Plus Cisplatin-HDFL Chemotherapy for the First-line Treatment of Advanced Gastric Cancer

Who this might be right for
Metastatic Gastric Cancer
National Taiwan University Hospital 40
Early research (Phase 1)Study completedNCT01337765
What this trial is testing

Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor Patients

Who this might be right for
Unspecified Adult Solid Tumor, Protocol SpecificSolid Tumor
Pfizer 29
Large-scale testing (Phase 3)Study completedNCT00604357
What this trial is testing

CNI-free de Novo Protocol in Patients Undergoing Liver Transplantation With Renal Impairment

Who this might be right for
End Stage Liver DiseaseImpaired Renal Function
University of Regensburg 27
Early research (Phase 1)Study completedNCT01266057
What this trial is testing

Sirolimus or Vorinostat and Hydroxychloroquine in Advanced Cancer

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 143
Testing effectiveness (Phase 2)Ended earlyNCT00811590
What this trial is testing

Pilot Study of mTOR Inhibitor Therapy in Peutz-Jeghers Syndrome

Who this might be right for
Peutz-Jeghers Syndrome
University of Utah 3
Early research (Phase 1)Study completedNCT01482156
What this trial is testing

Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsMetastatic Breast CancerMetastatic Renal Cell Carcinoma
Novartis Pharmaceuticals 46
Post-approval studies (Phase 4)Not Yet RecruitingNCT07203664
What this trial is testing

Use of Tacrolimus and MTOR Inhibitors With Anticipatory Therapy vs. Tacrolimus and Mycophenolic Acid With Universal Prophylaxis in Renal Recipients at High Risk of Posttransplant Cytomegalovirus.

Who this might be right for
Evaluate the Effectiveness of CMV Prevention Strategies in Kidney Transplant Recipients
Hospital Universitario La Paz 30
Testing effectiveness (Phase 2)Ended earlyNCT02438761
What this trial is testing

PF-05212384 (PKI-587) for t-AML/MDS or de Novo Relapsed or Refractory Acute Myeloid Leukemia (AML) (LAM-PIK)

Who this might be right for
Therapy-related Acute Myeloid Leukemia and Myelodysplastic SyndromeAcute Myeloid Leukemia, in Relapsede Novo Acute Myeloid Leukemia at Diagnostic
Institut Curie 10
Testing effectiveness (Phase 2)Looking for participantsNCT06727305
What this trial is testing

MTOR Inhibitors in Older Adults

Who this might be right for
Aging
University of Texas Southwestern Medical Center 60
Not applicableStudy completedNCT01358305
What this trial is testing

Protein Blends (Soy, Whey and Casein) for Muscle Synthesis

Who this might be right for
Muscle Synthesis
DuPont Nutrition and Health 19
Testing effectiveness (Phase 2)Study completedNCT02216786
What this trial is testing

Study of AZD2014 in Combination With Fulvestrant in Metastatic or Advanced Breast Cancer

Who this might be right for
Estrogen Receptor Positive Breast Cancer
Queen Mary University of London 333
Next Page